Betty Larson - Apr 29, 2025 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
EVP, Chief HR Officer
Signature
/s/ Kelly E. W. Grez as Attorney-in-Fact for Betty Larson
Stock symbol
MRK
Transactions as of
Apr 29, 2025
Transactions value $
$0
Form type
4
Date filed
5/1/2025, 05:58 PM
Previous filing
May 2, 2024
Next filing
May 2, 2025
SEC
View on sec.gov
This filing has been restated, see here for the amended filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MRK Common Stock 6.2K Apr 29, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Restricted Stock Unit Award $0 +6.26K $0.00 6.26K Apr 29, 2025 Common Stock 6.26K Direct F1, F2
transaction MRK Stock Option (Right to Buy) Award $0 +28.5K $0.00 28.5K Apr 29, 2025 Common Stock 28.5K $84.71 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F2 These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.
F3 The option vests and becomes exercisable in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.